Frank R. Lichtenberg
Affiliations: | Columbia University, New York, NY |
Area:
General EconomicsGoogle:
"Frank Lichtenberg"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lichtenberg FR. (2023) Has pharmaceutical innovation reduced the average cost of U.S. health care episodes? International Journal of Health Economics and Management |
| Lichtenberg FR. (2023) Number of drugs provided by the Pharmaceutical Benefits Scheme and mortality and hospital utilization in Australia, 2002-2019. Ssm - Population Health. 24: 101514 |
| Lichtenberg FR. (2022) The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries. Economics and Human Biology. 46: 101124 |
| Blankart KE, Lichtenberg FR. (2020) Are patients more adherent to newer drugs? Health Care Management Science |
| Lichtenberg FR. (2020) How cost-effective are new cancer drugs in the U.S.? Expert Review of Pharmacoeconomics & Outcomes Research. 1-17 |
| Lichtenberg FR. (2019) The impact of pharmaceutical innovation on the burden of disease in Canada, 2000-2016. Ssm - Population Health. 8: 100457 |
| Lichtenberg FR. (2019) The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis. Forum For Health Economics & Policy |
| Lichtenberg FR. (2019) How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000-2013. International Health |
| Lichtenberg FR. (2019) The impact of access to prescription drugs on disability in eleven European countries. Disability and Health Journal |
| Lichtenberg FR. (2019) The long-run impact of new medical ideas on cancer survival and mortality Economics of Innovation and New Technology. 28: 722-740 |